T. F. Wozniak

发表

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

T. Julian, J. Costantino, N. Wolmark, 2016, The Lancet.

Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer

G. Masters, C. Schneider, M. Guarino, 2018, Cancer medicine.

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy.

T. Julian, J. Costantino, N. Wolmark, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens.

M. Suhail, S. Fleishman, F. Mohammad, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic carcinomatous cirrhosis and hepatic hemosiderosis in a patient heterozygous for the H63D genotype.

T. F. Wozniak, M. L. Mitchell, M. Filippone, 2009, Archives of pathology & laboratory medicine.

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

R. Schilsky, R. Goldberg, H. Hurwitz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

R. Beart, N. Wolmark, D. Moore, 2015, Journal of the National Cancer Institute.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

N. Petrelli, R. Beart, N. Wolmark, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

T. Julian, J. Costantino, N. Wolmark, 2016, The Lancet.

Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04.

R. Beart, N. Wolmark, C. Ko, 2015, Annals of surgery.

Comparative effectiveness of sphincter-sparing surgery (SSS) versus abdomino-perineal resection (APR) in rectal cancer: Patient-reported outcomes (PROs) from NSABP R-04.

N. Wolmark, C. Ko, P. Ganz, 2012 .

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

T. Julian, J. Costantino, N. Wolmark, 2016, The Lancet.